The weight loss diet conversation in India changed significantly in December 2025, when Novo Nordisk launched Ozempic domestically. By March 2026, semaglutide’s patent had expired and over 40 Indian pharmaceutical companies were preparing generic GLP-1 drugs for the domestic market. What was once a niche diabetes medication whispered about in urban wellness circles is now becoming widely accessible. This deserves a calm, honest conversation — not a moral panic and not uncritical enthusiasm.
What GLP-1 Drugs Actually Do
GLP-1 stands for glucagon-like peptide-1, a hormone your gut naturally releases after eating. It signals fullness to the brain, slows gastric emptying and stimulates insulin release. GLP-1 receptor agonists like semaglutide mimic this hormone — keeping it elevated far longer than the body naturally would. The result is sustained appetite suppression and a significant reduction in food intake. The STEP 1 clinical trial found an average of 14.9% body weight reduction over 68 weeks. These are real outcomes for people with obesity-related metabolic conditions.
What a Weight Loss Diet Still Has to Do — Even on GLP-1 Medication
Prevent Muscle Loss
Studies on GLP-1-assisted weight loss show that a significant proportion of weight lost includes lean muscle mass. Research published in Nature Medicine found that without adequate protein intake and resistance activity, muscle loss during semaglutide treatment can be substantial. Lower muscle mass reduces resting metabolism, which makes weight maintenance harder once the drug is stopped. A weight loss diet running alongside medication must be high enough in protein — and structured enough in timing — to protect lean mass. Most people using GLP-1 drugs for cosmetic weight loss in India are not receiving this guidance.
Ensure Micronutrient Adequacy
GLP-1 drugs work by reducing appetite. They do not change what you choose to eat. When someone eats significantly less of everything, including nutrient-dense food, deficiencies accumulate. Iron, Vitamin B12, calcium and Vitamin D — already deficient in large proportions of the Indian population before medication — become more acute. A weight loss diet on GLP-1 medication needs to prioritise nutrient density, not just calorie reduction.
Build Habits That Survive the Drug
The largest GLP-1 withdrawal study, published in Diabetes, Obesity and Metabolism, found that participants regained two-thirds of their lost weight within one year of stopping semaglutide. The drug suppresses appetite while you take it. It does not rewire food patterns, stress responses or emotional eating habits. When medication stops, underlying patterns return. A weight loss diet that builds sustainable habits alongside medication is the only thing that protects long-term outcomes.
The Indian Context
India has 101 million people with diabetes and a rapidly growing obesity burden. For this population, GLP-1 drugs prescribed under medical supervision with nutritional support are a legitimate treatment tool. The concern is the cosmetic use case — urban professionals with moderate weight goals using injectable medication without medical supervision, nutritional guidance or a long-term plan. As Anupam Mittal noted publicly, Ozempic is already selling at Rs 8,800 per month in India, and a future where urban India ends up on monthly injections primarily for appearance is not an unreasonable concern.
The Honest Summary
- Work with a doctor who can assess whether medication is clinically appropriate for your situation
- Understand that a weight loss diet is not optional alongside GLP-1 drugs — it is what makes medication work safely
- Have a clear plan for what happens when you stop, because stopping without sustainable habits means regaining the weight
- Be cautious about unregulated generic GLP-1 products that will flood the Indian market
Whether you are considering medication or looking for a sustainable weight loss diet without it, personalised nutrition guidance makes the difference. Book a personalised nutrition consultation with Neelima at Raahi Wellness.